Funding for this research was provided by:
H2020 European Research Council (681524)
Dr. Mildred Scheel Stiftung für Krebsforschung
Deutsche Forschungsgemeinschaft (SFB1064/TP A13, SFB1243/A05)
Mehr LEBEN für Krebskranke Kinder – Bettina-Bräu-Stiftung
Deutsches Forschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München (G-509200-004)
Deutsche Krebshilfe (70112875)
Dr. Helmut Legerlotz Stiftung
Received: 20 August 2020
Accepted: 7 September 2020
First Online: 16 September 2020
Ethics approval and consent to participate
: For the two primary B-ALL patient samples, written informed consent was obtained from all patients or from parents/caregivers in cases when patients were minors. The study was performed in accordance with the ethical standards of the responsible committee on human experimentation (written approval by Ethikkommission des Klinikums der Ludwig-Maximilians-Universität Munich, number 068–08 and 222–10) and with the Helsinki Declaration of 1975, as revised in 2000.Animal trials were performed in accordance with the current ethical standards of the official committee on animal experimentation (written approval by Regierung von Oberbayern, ExternalRef removed; July 2010, number 55.2–1-54-2531-95-10; July 2010, 55.2–1-54-2531.6-10-10; January 2016, ROB-55.2Vet-2532.Vet_02–15-193; May 2016, ROB-55.2Vet-2532.Vet_02–16-7 and August 2016, ROB-55.2Vet-2532.Vet_03–16-56).
: Not applicable.
: The authors declare that they have no competing interests.